发明名称 |
USE OF THE COMPOUND 2-METHOXYPHENYL-1-METHYL-5P-METHYLBENZOYL-PYRROL-2-ACETAMIDO ACETATE FOR THE PRODUCTION OF AN ANTI-INFLAMMATORY DRUG WITH PREVENTION OF GASTRIC HYPERSECRETION AND RENAL IMPAIRMENT |
摘要 |
<p>The present invention relates to the use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate (known also as amtolmetin guacyl and indicated in the present description also as MED 15) for the production of a NSAID for treating an inflammatory pathological condition with effect of prevention of NSAID-related hydrochloric acid hypersecretion, wherein in order to show its gastro-protective effect same compound has to be administered on empty stomach and without a simultaneous assumption of H1 receptor inhibiting drugs.</p> |
申请公布号 |
SI1024807(T1) |
申请公布日期 |
2003.10.31 |
申请号 |
SI19970030527T |
申请日期 |
1997.08.08 |
申请人 |
MEDOSAN RICERCA S.R.L.;SIGMA TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. |
发明人 |
ANZALONE SERGIO |
分类号 |
A61K31/40;A61P29/00;(IPC1-7):A61K31/40;A61P13/12 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|